Assessment of first-trimester utero-placental vascular morphology by 3D power Doppler ultrasound image analysis using a skeletonization algorithm: the Rotterdam Periconception Cohort.


Journal

Human reproduction (Oxford, England)
ISSN: 1460-2350
Titre abrégé: Hum Reprod
Pays: England
ID NLM: 8701199

Informations de publication

Date de publication:
31 10 2022
Historique:
received: 06 01 2022
revised: 16 08 2022
pubmed: 21 9 2022
medline: 4 11 2022
entrez: 20 9 2022
Statut: ppublish

Résumé

Can three-dimensional (3D) Power Doppler (PD) ultrasound and a skeletonization algorithm be used to assess first-trimester development of the utero-placental vascular morphology? The application of 3D PD ultrasonography and a skeletonization algorithm facilitates morphologic assessment of utero-placental vascular development in the first trimester and reveals less advanced vascular morphologic development in pregnancies with placenta-related complications than in pregnancies without placenta-related complications. Suboptimal development of the utero-placental vasculature is one of the main contributors to the periconceptional origin of placenta-related complications. The nature and attribution of aberrant vascular structure and branching patterns remain unclear, as validated markers monitoring first-trimester utero-placental vascular morphologic development are lacking. In this prospective observational cohort, 214 ongoing pregnancies were included before 10 weeks gestational age (GA) at a tertiary hospital between January 2017 and July 2018, as a subcohort of the ongoing Rotterdam Periconception Cohort study. By combining 3D PD ultrasonography and virtual reality, utero-placental vascular volume (uPVV) measurements were obtained at 7, 9 and 11 weeks GA. A skeletonization algorithm was applied to the uPVV measurements to generate the utero-placental vascular skeleton (uPVS), a network-like structure containing morphologic characteristics of the vasculature. Quantification of vascular morphology was performed by assigning a morphologic characteristic to each voxel in the uPVS (end-, vessel-, bifurcation- or crossing-point) and calculating total vascular network length. A Mann-Whitney U test was performed to investigate differences in morphologic development of the first-trimester utero-placental vasculature between pregnancies with and without placenta-related complications. Linear mixed models were used to estimate trajectories of the morphologic characteristics in the first trimester. All morphologic characteristics of the utero-placental vasculature increased significantly in the first trimester (P < 0.005). In pregnancies with placenta-related complications (n = 54), utero-placental vascular branching was significantly less advanced at 9 weeks GA (vessel points P = 0.040, bifurcation points P = 0.050, crossing points P = 0.020, total network length P = 0.023). Morphologic growth trajectories remained similar after adjustment for parity, conception mode, foetal sex and occurrence of placenta-related complications. The tertiary setting of this prospective observational study provides high internal, but possibly limited external, validity. Extrapolation of the study's findings should therefore be addressed with caution. The uPVS enables assessment of morphologic development of the first-trimester utero-placental vasculature. Further investigation of this innovative methodology needs to determine its added value for the assessment of (patho-) physiological utero-placental vascular development. This research was funded by the Department of Obstetrics and Gynecology of the Erasmus MC, University Medical Centre, Rotterdam, The Netherlands. There are no conflicts of interest. Registered at the Dutch Trial Register (NTR6854).

Identifiants

pubmed: 36125007
pii: 6705361
doi: 10.1093/humrep/deac202
pmc: PMC9627684
doi:

Types de publication

Observational Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2532-2545

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.

Références

Placenta. 2018 Jan;61:96-102
pubmed: 29277277
Biol Reprod. 2016 Aug;95(2):43
pubmed: 27335074
Placenta. 2012 Oct;33(10):782-7
pubmed: 22835679
BJOG. 2021 Jul;128(8):1386-1387
pubmed: 33942468
Hum Reprod. 2018 Aug 1;33(8):1430-1441
pubmed: 29955830
Am J Obstet Gynecol. 2019 Nov;221(5):437-456
pubmed: 31163132
Am Fam Physician. 2019 Nov 15;100(10):649-650
pubmed: 31730305
Placenta. 2019 Sep 1;84:32-36
pubmed: 31279487
Fetal Diagn Ther. 2019;45(6):381-393
pubmed: 30021205
Radiographics. 2009 Sep-Oct;29(5):1371-91
pubmed: 19755601
Placenta. 2021 May;108:81-90
pubmed: 33823358
Placenta. 1980 Jan-Mar;1(1):3-19
pubmed: 7443635
J Perinat Med. 2006;34(6):447-58
pubmed: 17140293
PLoS One. 2017 Jun 1;12(6):e0178675
pubmed: 28570600
Ultrasound Obstet Gynecol. 2012 Jul;40(1):75-80
pubmed: 22009687
Reprod Sci. 2017 May;24(5):753-761
pubmed: 27733657
Hum Pathol. 1997 Mar;28(3):353-8
pubmed: 9042801
Obstet Gynecol Annu. 1972;1:177-91
pubmed: 4669123
Placenta. 1991 May-Jun;12(3):269-76
pubmed: 1754575
Diabetes Res Clin Pract. 2018 Nov;145:20-30
pubmed: 29852233
Mol Cell Endocrinol. 2020 Mar 1;503:110699
pubmed: 31899258
Ultrasound Obstet Gynecol. 2016 Sep;48(3):333-9
pubmed: 26909664
Am J Obstet Gynecol. 2015 Oct;213(4 Suppl):S6.e1, S6-8
pubmed: 26428504
Ultrasound Obstet Gynecol. 2013 Nov;42(5):577-84
pubmed: 23996572
Hum Reprod. 1997 Jul;12(7):1577-81
pubmed: 9262300
Placenta. 2017 Dec;60:134-139
pubmed: 28651899
Placenta. 2009 Jun;30(6):473-82
pubmed: 19375795
Hum Reprod. 2017 Dec 01;32(12):2382-2393
pubmed: 29136193
Obstet Gynecol Clin North Am. 2020 Mar;47(1):17-28
pubmed: 32008667
Best Pract Res Clin Obstet Gynaecol. 2018 Oct;52:3-12
pubmed: 29779863
BJOG. 2019 Mar;126(4):472-484
pubmed: 30358080
J Dev Orig Health Dis. 2021 Apr;12(2):168-178
pubmed: 32746961
Ultraschall Med. 2020 Apr;41(2):138-145
pubmed: 32107757
Hum Reprod. 2021 Feb 18;36(3):571-586
pubmed: 33600565
Horm Res Paediatr. 2016;86(5):357-360
pubmed: 27685026
Am J Obstet Gynecol. 2011 Mar;204(3):193-201
pubmed: 21094932
Int J Mol Sci. 2019 Jul 02;20(13):
pubmed: 31269775
Ultrasound Med Biol. 2018 Mar;44(3):522-531
pubmed: 29305123
Am J Obstet Gynecol. 2019 Sep;221(3):219-226
pubmed: 30738027
Placenta. 2009 Mar;30(3):220-2
pubmed: 19185915
Am J Obstet Gynecol. 2022 Feb;226(2S):S895-S906
pubmed: 32971013
Int J Epidemiol. 2016 Apr;45(2):374-81
pubmed: 26224071
Cell Mol Life Sci. 2019 Sep;76(18):3479-3496
pubmed: 31049600
Placenta. 2014 Oct;35(10):808-15
pubmed: 25145956
Obstet Gynecol Surv. 2011 Apr;66(4):225-39
pubmed: 21756405
Hypertension. 2019 Apr;73(4):757-766
pubmed: 30686084
Ultrasound Med Biol. 2014 Aug;40(8):1796-803
pubmed: 24798392
Int J Epidemiol. 2021 Nov 10;50(5):1426-1427l
pubmed: 34097026
Am J Obstet Gynecol. 2017 Mar;216(3):287.e1-287.e16
pubmed: 28034657
Ultrasound Obstet Gynecol. 2012 Aug;40(2):171-8
pubmed: 22102536
Hum Reprod Update. 2013 Nov-Dec;19(6):640-55
pubmed: 23959022

Auteurs

Eline S de Vos (ES)

Department of Obstetrics and Gynecology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.

Anton H J Koning (AHJ)

Department of Pathology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.

Régine P M Steegers-Theunissen (RPM)

Department of Obstetrics and Gynecology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.

Sten P Willemsen (SP)

Department of Obstetrics and Gynecology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Department of Biostatistics, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.

Bas B van Rijn (BB)

Department of Obstetrics and Gynecology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.

Eric A P Steegers (EAP)

Department of Obstetrics and Gynecology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.

Annemarie G M G J Mulders (AGMGJ)

Department of Obstetrics and Gynecology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH